MESOX has just won the National Start-Up Award from Medilink UK, building upon the earlier regional win in the Midlands from Medilink Midlands in May this year.
The judges highlighted two compelling reasons for their choice:
MESOX’s work to develop advanced carrier technology with a mission to transform the development of pharmaceuticals, enhance bioavailability, and ultimately improve patient treatment.
The potential of the business to become a unique international research-based pharmaceutical company in the Midlands.
Our CEO and Founder, Dr. Ali Al-khattawi, described the win as a “proud moment for the MESOX team and a testament to the potential of our company. To be selected from among hundreds of great life science start-ups in the UK is a great privilege. This highlights the transformative potential of our company in advancing the formulation development of innovative therapeutics.”
The Medilink UK National Healthcare Business Awards showcase the best and brightest in the life science and healthcare technology sectors, recognizing companies that demonstrate exceptional innovation, commercial success, and patient impact.
MESOX’s win is a significant achievement, underscoring the company’s dedication to advancing healthcare through cutting-edge research and development.
